Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Setareh A Williams

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
Seminars in Arthritis and Rheumatism|February 10, 2019
Cost-effectiveness of sequential treatment with abaloparatide vs. teriparatide for United States women at increased risk of fractureMickael Hiligsmann, Setareh A Williams, Lorraine A Fitzpatrick, et al.
Psychosomatic Medicine|January 31, 2002
Depression and risk of heart failure among the elderly: a prospective community-based studySetareh A Williams, Stanislav V Kasl, Asefeh Heiat, et al.
Seminars in Arthritis and Rheumatism|March 13, 2020
Cost-effectiveness of sequential treatment with abaloparatide followed by alendronate vs. alendronate monotherapy in women at increased risk of fracture: A US payer perspectiveMickael Hiligsmann, Setareh A Williams, Lorraine A Fitzpatrick, et al.
Clinical Drug Investigation|February 27, 2021
Phase 1b Evaluation of Abaloparatide Solid Microstructured Transdermal System (Abaloparatide-sMTS) in Postmenopausal Women with Low Bone Mineral DensityPaul D Miller, Steven Troy, Richard J Weiss, et al.
Respiratory Research|April 23, 2015
Comparative effectiveness of budesonide/formoterol combination and fluticasone/salmeterol combination among chronic obstructive pulmonary disease patients new to controller treatment: a US administrative claims database studyDavid M Kern, Jill Davis, Setareh A Williams, et al.
Journal of Drug Assessment|November 7, 2019
Impact of fractures on quality of life in patients with osteoporosis: a US cross-sectional surveyT Gold, Setareh A Williams, Richard J Weiss, et al.
Clinical Therapeutics|October 26, 2006
Impact of rosuvastatin use on costs and outcomes in patients at high risk for cardiovascular disease in US managed care and medicare populations: A data analysisDaniel M Huse, Xue Song, Ronald J Ozminkowski, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|July 7, 2005
Association between short-term effectiveness of statins and long-term adherence to lipid-lowering therapyJoshua S Benner, Michael F Pollack, Timothy W Smith, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 3, 2014
Comparative effectiveness of budesonide-formoterol combination and fluticasone-salmeterol combination for asthma management: a United States retrospective database analysisOzgur Tunceli, Setareh A Williams, David M Kern, et al.
International Journal of Chronic Obstructive Pulmonary Disease|July 30, 2014
A US database study characterizing patients initiating a budesonide-formoterol combination versus tiotropium bromide as initial maintenance therapy for chronic obstructive pulmonary diseaseDavid M Kern, Setareh A Williams, Ozgur Tunceli, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Seminars in Arthritis and Rheumatism|February 10, 2019
Cost-effectiveness of sequential treatment with abaloparatide vs. teriparatide for United States women at increased risk of fractureMickael Hiligsmann, Setareh A Williams, Lorraine A Fitzpatrick, et al.
Psychosomatic Medicine|January 31, 2002
Depression and risk of heart failure among the elderly: a prospective community-based studySetareh A Williams, Stanislav V Kasl, Asefeh Heiat, et al.
Seminars in Arthritis and Rheumatism|March 13, 2020
Cost-effectiveness of sequential treatment with abaloparatide followed by alendronate vs. alendronate monotherapy in women at increased risk of fracture: A US payer perspectiveMickael Hiligsmann, Setareh A Williams, Lorraine A Fitzpatrick, et al.
Clinical Drug Investigation|February 27, 2021
Phase 1b Evaluation of Abaloparatide Solid Microstructured Transdermal System (Abaloparatide-sMTS) in Postmenopausal Women with Low Bone Mineral DensityPaul D Miller, Steven Troy, Richard J Weiss, et al.
Respiratory Research|April 23, 2015
Comparative effectiveness of budesonide/formoterol combination and fluticasone/salmeterol combination among chronic obstructive pulmonary disease patients new to controller treatment: a US administrative claims database studyDavid M Kern, Jill Davis, Setareh A Williams, et al.
Journal of Drug Assessment|November 7, 2019
Impact of fractures on quality of life in patients with osteoporosis: a US cross-sectional surveyT Gold, Setareh A Williams, Richard J Weiss, et al.
Clinical Therapeutics|October 26, 2006
Impact of rosuvastatin use on costs and outcomes in patients at high risk for cardiovascular disease in US managed care and medicare populations: A data analysisDaniel M Huse, Xue Song, Ronald J Ozminkowski, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|July 7, 2005
Association between short-term effectiveness of statins and long-term adherence to lipid-lowering therapyJoshua S Benner, Michael F Pollack, Timothy W Smith, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 3, 2014
Comparative effectiveness of budesonide-formoterol combination and fluticasone-salmeterol combination for asthma management: a United States retrospective database analysisOzgur Tunceli, Setareh A Williams, David M Kern, et al.
International Journal of Chronic Obstructive Pulmonary Disease|July 30, 2014
A US database study characterizing patients initiating a budesonide-formoterol combination versus tiotropium bromide as initial maintenance therapy for chronic obstructive pulmonary diseaseDavid M Kern, Setareh A Williams, Ozgur Tunceli, et al.
Pageof 5